Day: July 6, 2021

NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) — Apollo Investment Corporation (NASDAQ: AINV) (the “Company”) announced today that it will report results for the quarter ended June 30, 2021, after market close on Thursday, August 5, 2021. The Company will also host a conference call on Thursday, August 5, 2021 at 5:00 p.m. Eastern Time. All interested parties are welcome to participate in the conference call by dialing (877) 876-9173 approximately 5-10 minutes prior to the call; international callers should dial (785) 424-1667. Participants should reference either Apollo Investment Corporation Q1 2022 Earnings or Conference ID: AINVQ122 when prompted. A simultaneous webcast of the conference call will be available to the public on a listen-only basis and can be accessed through the Events Calendar in the Shareholders section of our website...

HOUSTON, July 06, 2021 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) announced they will release second-quarter 2021 earnings after market close on Tuesday, August 3, 2021 and will hold a joint webcast on the same day as follows: What: Second-quarter 2021 earnings webcast When: Tuesday, August 3, 2021 5:30 p.m. ET; 4:30 p.m. CT Where: www.plainsallamerican.com or https://edge.media-server.com/mmc/p/3wef49ho How: Live over the internet – log on at either of the addresses above Specific items we intend to address on the call include:PAA’s second-quarter 2021 performance; Capitalization and liquidity; and Financial and operating guidanceThe slide presentation accompanying the conference call materials will be posted prior to the call at www.plainsallamerican.com...

Pennsauken, N.J., July 06, 2021 (GLOBE NEWSWIRE) —  J & J Snack Foods Corp. (NASDAQ-JJSF) announced today that its conference call to discuss third quarter 2021 results is scheduled for Tuesday July 27th at 10:00 am Eastern time. The phone number and confirmation number for the call are 1 (847) 585-4422 and 6046 817#. The Company stated that it expects to release its results for the quarter ended June 26th, 2021, at 4:00 pm Eastern time on Monday July 26th. J&J Snack Foods Corp. (NASDAQ: JJSF) is a leader and innovator in the snack food industry, providing innovative, niche and affordable branded snack foods and beverages to foodservice and retail supermarket outlets. Manufactured and distributed nationwide, our principal products include SUPERPRETZEL, the  #1 soft pretzel brand in the world, as well as internationally...

TORONTO, July 06, 2021 (GLOBE NEWSWIRE) — Osisko Mining Inc. (OSK:TSX “Osisko” or the “Corporation”), is pleased to announce that it has published its 2020 Sustainable Development report which provides a detailed overview of the Company’s environmental, social, and governance (ESG) performance and economic contributions to the communities in which we operate. The report is available on the Osisko website www.osiskomining.com in English and French. In 2020, Osisko Mining worked to responsibly manage the effects of the COVID-19 pandemic; our top focus was keeping our workers and communities healthy and safe. We continued to deliver on our commitment of being a good corporate citizen by engaging with stakeholders, concentrating on environmental stewardship, and being an economic stimulus for our host communities. We strengthened our...

WATERTOWN, Mass., July 06, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the closing of its upsized underwritten public offering of 5,468,250 shares of its common stock at a public offering price of $47.00 per share, which includes 713,250 shares issued upon the exercise in full by the underwriters of their option to purchase additional shares of common stock. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, were approximately $257.0 million. Morgan Stanley, J.P. Morgan, Cowen, and Guggenheim Securities acted as joint book-running managers for the offering. A registration statement...

Third and fourth sales markets in Texas include signature test drive delivery service SAN FRANCISCO, July 06, 2021 (GLOBE NEWSWIRE) — Leading used car ecommerce platform Shift (NASDAQ: SFT) has launched two new markets for consumers to buy its cars in Texas. With this launch, consumers in the Dallas-Fort Worth region can now buy and sell vehicles directly with Shift, using the company’s unique direct-to-consumer, at-home service. Dallas and Fort Worth are the third and fourth full-service markets in Texas where consumers can purchase cars from Shift, with this launch coming on the heels of Shift’s recent launch of its first two full-service Texas markets in the Austin and San Antonio regions. “We are excited to continue expanding our product offering to car buyers in the Texas market,” commented Shift Co-CEO Toby Russell. “We believe...

CALGARY, Alberta, July 06, 2021 (GLOBE NEWSWIRE) — Eguana Technologies Inc. (“Eguana” or the “Company”) (TSX-V: EGT, OTCQB: EGTYF) is pleased to announce that its Evolve system will be immediately deployed under the recently announced Emergency Demand Response Program (EDRP) by the Hawaii PUC (Public Utility Commission), kick starting advanced Virtual Power Plant activities on Oahu. Due to the pending retirement of the AES coal generating station in September 2022, and delays in renewable/storage projects previously planned to replace its capacity, the PUC has ordered the procurement of 50MW of scheduled dispatch services, or approximately 10,000 5kW residential energy storage systems, from distributed energy storage resources to be installed alongside rooftop solar. Homeowners that choose to purchase and...

NEW YORK, July 06, 2021 (GLOBE NEWSWIRE) — MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets, today announced monthly trading volume for June 2021 of $567.0 billion consisting of $239.5 billion in credit volume and $327.5 billion in rates volume. The Company also reported preliminary variable transaction fees per million (“FPM”) for the quarter ended June 30, 2021 of $174 for U.S. high-grade, $194 for other credit, $184 for total credit and $3.90 for rates. The FPM for the quarter ended June 30, 2021 are preliminary and may be revised in subsequent updates and public filings. The Company undertakes no obligation to update any fee information in future press releases. Reported...

DALLAS, July 06, 2021 (GLOBE NEWSWIRE) — Builders FirstSource, Inc. (Nasdaq: BLDR) (“Builders FirstSource” or the “Company”), today announced that it will transfer the listing of its common stock from the Nasdaq Stock Market to the New York Stock Exchange (“NYSE”). Builders FirstSource expects to commence trading as a NYSE-listed company at market open on July 19, 2021. The Company’s common stock will continue trading under the ticker symbol “BLDR” after the transfer. “With the merger of Builders FirstSource and BMC creating the nation’s premier supplier of building materials and services, we felt it was important for our Company to be listed on the NYSE, which is the preferred exchange for our industry,” said Dave Flitman, President and Chief Executive Officer of Builders FirstSource. “The NYSE has a long and...

BELTSVILLE, Md., July 06, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the initiation of a Phase 1/2 clinical trial for NC762, a humanized B7-H4 monoclonal antibody. “We are pleased to have initiated the clinical trial of our third product candidate,” said Michael Richman, NextCure’s president and chief executive officer. “This represents an important expansion of our pipeline of novel immunomedicines designed to treat patients who are not adequately addressed by currently available therapies. We look forward to reporting initial data from this trial in mid-2022.” “NC762 is an innovative immunomedicine that directly inhibits tumor growth by a unique,...